85 related articles for article (PubMed ID: 15818805)
1. Gene symbol: TP53. Disease: squamous cell carcinoma of head and neck.
Roychoudhury S; Mitra S
Hum Genet; 2005 Feb; 116(3):233. PubMed ID: 15818805
[No Abstract] [Full Text] [Related]
2. TP53 mutations in head and neck cancer.
Perrone F; Bossi P; Licitra L
N Engl J Med; 2008 Mar; 358(11):1194-5; author reply 1195. PubMed ID: 18340660
[No Abstract] [Full Text] [Related]
3. TP53 mutations in head and neck cancer.
Beutner D; Klussmann JP; Guntinas-Lichius O
N Engl J Med; 2008 Mar; 358(11):1194; author reply 1195. PubMed ID: 18337610
[No Abstract] [Full Text] [Related]
4. NF-kappaB gene signatures and p53 mutations in head and neck squamous cell carcinoma.
Ferris RL; Grandis JR
Clin Cancer Res; 2007 Oct; 13(19):5663-4. PubMed ID: 17908953
[No Abstract] [Full Text] [Related]
5. p53 apoptotic response to DNA damage dependent on bcl2 but not bax in head and neck squamous cell carcinoma lines.
Crowe DL; Sinha UK
Head Neck; 2006 Jan; 28(1):15-23. PubMed ID: 16302195
[TBL] [Abstract][Full Text] [Related]
6. [Oncogenes and tumor suppressor genes in head and neck squamous cell carcinomas].
Maestro R; Dolcetti R
Acta Otorhinolaryngol Ital; 1996 Jun; 16(3 Suppl 54):21-6. PubMed ID: 9036736
[No Abstract] [Full Text] [Related]
7. Staging of head and neck cancer.
Denic S
N Engl J Med; 1995 Jun; 332(26):1789; author reply 1789-90. PubMed ID: 7619167
[No Abstract] [Full Text] [Related]
8. Staging of head and neck cancer.
Kao GD; Rudoltz M
N Engl J Med; 1995 Jun; 332(26):1788-9; author reply 1789-90. PubMed ID: 7760903
[No Abstract] [Full Text] [Related]
9. Refined characterization of head and neck squamous cell carcinomas expressing a seemingly wild-type p53 protein.
Leng K; Schlien S; Bosch FX
J Oral Pathol Med; 2006 Jan; 35(1):19-24. PubMed ID: 16393249
[TBL] [Abstract][Full Text] [Related]
10. Comparison of p16(INK4a) expression with p53 alterations in head and neck cancer by tissue microarray analysis.
Karsai S; Abel U; Roesch-Ely M; Affolter A; Hofele C; Joos S; Plinkert PK; Bosch FX
J Pathol; 2007 Feb; 211(3):314-22. PubMed ID: 17152048
[TBL] [Abstract][Full Text] [Related]
11. Genetic profile of head and neck squamous cell carcinoma: clinical implications.
Agada FO; Patmore H; Alhamarneh O; Stafford ND; Greenman J
J Laryngol Otol; 2009 Mar; 123(3):266-72. PubMed ID: 18694533
[TBL] [Abstract][Full Text] [Related]
12. The possible role of TP53 mutation status in the treatment of squamous cell carcinomas of the head and neck (HNSCC) with radiotherapy with different overall treatment times.
Eriksen JG; Alsner J; Steiniche T; Overgaard J
Radiother Oncol; 2005 Aug; 76(2):135-42. PubMed ID: 16024113
[TBL] [Abstract][Full Text] [Related]
13. Single-nucleotide polymorphisms at the TP53-binding or responsive promoter regions of BAX and BCL2 genes and risk of squamous cell carcinoma of the head and neck.
Chen K; Hu Z; Wang LE; Sturgis EM; El-Naggar AK; Zhang W; Wei Q
Carcinogenesis; 2007 Sep; 28(9):2008-12. PubMed ID: 17693666
[TBL] [Abstract][Full Text] [Related]
14. P53 codon 72 polymorphism in squamous cell carcinoma of the head and neck region.
Brant O; Hoffmann M; Kanappilly A; Görögh T; Gottschlich S
Anticancer Res; 2007; 27(5A):3301-5. PubMed ID: 17970074
[TBL] [Abstract][Full Text] [Related]
15. Frequent deletion and down-regulation of ING4, a candidate tumor suppressor gene at 12p13, in head and neck squamous cell carcinomas.
Gunduz M; Nagatsuka H; Demircan K; Gunduz E; Cengiz B; Ouchida M; Tsujigiwa H; Yamachika E; Fukushima K; Beder L; Hirohata S; Ninomiya Y; Nishizaki K; Shimizu K; Nagai N
Gene; 2005 Aug; 356():109-17. PubMed ID: 15935570
[TBL] [Abstract][Full Text] [Related]
16. 172G>T variant in the 5' untranslated region of DNA repair gene RAD51 reduces risk of squamous cell carcinoma of the head and neck and interacts with a P53 codon 72 variant.
Lu J; Wang LE; Xiong P; Sturgis EM; Spitz MR; Wei Q
Carcinogenesis; 2007 May; 28(5):988-94. PubMed ID: 17118968
[TBL] [Abstract][Full Text] [Related]
17. Differential diagnosis of pulmonary carcinoma following head and neck cancer by genetic analysis.
Geurts TW; van Velthuysen ML; Broekman F; van Huysduynen TH; van den Brekel MW; van Zandwijk N; van Tinteren H; Nederlof P; Balm AJ; Brakenhoff RH
Clin Cancer Res; 2009 Feb; 15(3):980-5. PubMed ID: 19188169
[TBL] [Abstract][Full Text] [Related]
18. Fine-mapping loss of gene architecture at the CDKN2B (p15INK4b), CDKN2A (p14ARF, p16INK4a), and MTAP genes in head and neck squamous cell carcinoma.
Worsham MJ; Chen KM; Tiwari N; Pals G; Schouten JP; Sethi S; Benninger MS
Arch Otolaryngol Head Neck Surg; 2006 Apr; 132(4):409-15. PubMed ID: 16618910
[TBL] [Abstract][Full Text] [Related]
19. Inverse relationship between human papillomavirus-16 infection and disruptive p53 gene mutations in squamous cell carcinoma of the head and neck.
Westra WH; Taube JM; Poeta ML; Begum S; Sidransky D; Koch WM
Clin Cancer Res; 2008 Jan; 14(2):366-9. PubMed ID: 18223210
[TBL] [Abstract][Full Text] [Related]
20. Unraveling the chromosomal aberrations of head and neck squamous cell carcinoma: a review.
Patmore HS; Cawkwell L; Stafford ND; Greenman J
Ann Surg Oncol; 2005 Oct; 12(10):831-42. PubMed ID: 16132373
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
